SCHEMBL30497271

SCHEMBL30497271

O=C(O)c1nc2ccccc2n1CC1CCOC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 3/20 0.47
BAZ2A Q9UIF9 2/20 0.47
ERCC5 P28715 1/20 0.45
FEN1 P39748 1/20 0.45
TLR7 Q9NYK1 7/20 0.44
KDM4E B2RXH2 3/20 0.44
ALDH1A1 P00352 3/20 0.44
POLB P06746 3/20 0.44
HSD17B10 Q99714 2/20 0.44
GLA P06280 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
THRB P10828 1/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CNR1 P21554 1/20 0.43
CNR2 P34972 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30497309 0.93 BRD4 (0.52) BRD4BAZ2AFEN1KDM4EALDH1A1
SCHEMBL22029484 0.86 BRD4 (0.51) BRD4BAZ2AKDM4EALDH1A1POLB
SCHEMBL29924458 0.82 PTGER4 (0.48) KDM4EALDH1A1POLBHSD17B10GLA
SCHEMBL30899106 0.82 PTGER4 (0.48) KDM4EALDH1A1POLBHSD17B10GLA
SCHEMBL30497263 0.79 KCNH2 (0.55) KDM4EALDH1A1POLBHSD17B10GLA
SCHEMBL30497300 0.74 PDE4B (0.52) TP53PDE10A
SCHEMBL13011130 0.74 CNR2 (0.55) ERCC5FEN1KDM4EALDH1A1HPGD
SCHEMBL30497303 0.72 OGFRL1 (0.53) TP53
SCHEMBL3619365 0.71 MAPK1 (0.61) KDM4EALDH1A1POLBHSD17B10GLA
SCHEMBL11145191 0.71 KDM4E (0.65) KDM4EALDH1A1HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12497382-B2 GLP-1R modulating compounds GILEAD SCIENCES, INC. (US) 2025-12-16 US disclosed
US-20230391747-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2023-12-07 US disclosed
US-11702404-B2 GLP-1R modulating compounds GILEAD SCIENCES, INC. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702404-B2 GLP-1R modulating compounds GLP1R, GIPR, GPR119 BRD4 1246/4885BAZ2A 2614/4885ERCC5 4782/4885
US-20230391747-A1 GLP-1R MODULATING COMPOUNDS GLP1R, GIPR, GPR119 BRD4 1246/4885BAZ2A 2614/4885ERCC5 4782/4885
US-12497382-B2 GLP-1R modulating compounds GLP1R, GIPR, GPR119 BRD4 1246/4885BAZ2A 2614/4885ERCC5 4782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.